Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.06
-0.46 (-5.45%)
At close: Nov 16, 2026, 4:00 PM EST
8.10
+0.04 (0.50%)
After-hours: Nov 16, 2026, 7:59 PM EST

Novavax Revenue

Novavax had revenue of $68.30M in the quarter ending September 30, 2026, a decrease of -3.05%. This brings the company's total for the last twelve months to $411.65M, down -61.33% year-over-year. In the year 2025, Novavax had annual revenue of $1.12B with 64.69% growth. That makes Novavax the 12,427th largest company in the world by revenue and 2,413th in the United States.

Revenue (ttm)
$411.65M
Revenue Growth
-61.33%
P/S Ratio
3.23
Revenue / Employee
$549,598
Employees
749
Market Cap
1.33B

Revenue Chart

Revenue by Geography

  • Rest of North America 575.67M 51.2%
  • United States 405.61M 36.1%
  • Rest of The World 126.46M 11.3%
  • Europe 15.74M 1.4%
Fiscal year ended Dec 31, 2025 See the full Novavax breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.12B441.32M64.69%
Dec 31, 2024682.16M-301.54M-30.65%
Dec 31, 2023983.71M-998.17M-50.36%
Dec 31, 20221.98B835.58M72.89%
Dec 31, 20211.15B670.69M141.02%
Dec 31, 2020475.60M456.94M2,448.48%
Dec 31, 201918.66M-15.63M-45.57%
Dec 31, 201834.29M3.11M9.98%
Dec 31, 201731.18M15.82M103.06%
Dec 31, 201615.35M-20.90M-57.65%
Dec 31, 201536.25M5.59M18.24%
Dec 31, 201430.66M9.74M46.59%
Dec 31, 201320.92M-1.16M-5.26%
Dec 31, 201222.08M7.39M50.30%
Dec 31, 201114.69M14.35M4,182.22%
Dec 31, 2010343.00K18.00K5.54%
Dec 31, 2009325.00K-739.00K-69.45%
Dec 31, 20081.06M-449.00K-29.68%
Dec 31, 20071.51M-225.00K-12.95%
Dec 31, 20061.74M-3.61M-67.47%
Dec 31, 20055.34M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Innoviva438.32M
Nuvation Bio201.73M
AnaptysBio60.04M
Intellia Therapeutics52.89M
Ocular Therapeutix50.38M
Absci1.49M
Revenue Rankings